BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6861131)

  • 1. Effects of vincristine on cell survival, cell cycle progression, and mitotic accumulation in asynchronously growing Sarcoma 180 cells.
    Mujagic H; Chen SS; Geist R; Occhipinti SJ; Conger BM; Smith CA; Schuette WH; Shackney SE
    Cancer Res; 1983 Aug; 43(8):3591-7. PubMed ID: 6861131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schedule dependence of vincristine lethality in Sarcoma 180 cells following partial synchronization with hydroxyurea.
    Mujagic H; Conger BM; Smith CA; Occhipinti SJ; Schuette WH; Shackney SE
    Cancer Res; 1983 Aug; 43(8):3598-603. PubMed ID: 6861132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of aclacinomycin on cell survival and cell cycle progression of cultured mammalian cells.
    Traganos F; Staiano-Coico L; Darzynkiewicz Z; Melamed MR
    Cancer Res; 1981 Jul; 41(7):2728-37. PubMed ID: 6166368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative cell killing and kinetic effects of vincristine or vindesine in mammalian cell lines.
    Hill BT; Whelan RD
    J Natl Cancer Inst; 1981 Aug; 67(2):437-43. PubMed ID: 6943380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 7-con-O-methylnogarol on DNA synthesis, survival, and cell cycle progression of Chinese hamster ovary cells.
    Adams EG; Crampton SL; Bhuyan BK
    Cancer Res; 1981 Dec; 41(12 Pt 1):4981-7. PubMed ID: 6458356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation and release of vinblastine and vincristine by HeLa cells: light microscopic, cinematographic, and biochemical study.
    Lengsfeld AM; Dietrich J; Schultze-Maurer B
    Cancer Res; 1982 Sep; 42(9):3798-805. PubMed ID: 7105045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ellipticine on cell survival and cell cycle progression in cultured mammalian cells.
    Traganos F; Staiano-Coico L; Darzynkiewicz Z; Melamed MR
    Cancer Res; 1980 Jul; 40(7):2390-9. PubMed ID: 6155993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Action of dihydroxyanthraquinone on cell cycle progression and survival of a variety of cultured mammalian cells.
    Traganos F; Evenson DP; Staiano-Coico L; Darzynkiewicz Z; Melamed MR
    Cancer Res; 1980 Mar; 40(3):671-81. PubMed ID: 6162553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR.
    Tang XQ; Bi H; Feng JQ; Cao JG
    Acta Pharmacol Sin; 2005 Aug; 26(8):1009-16. PubMed ID: 16038636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-dependent cell inactivation by vincristine alone or in combination with 1-propargyl-5-chloropyrimidin-2-one.
    Wibe E
    Cancer Res; 1980 Jun; 40(6):2069-73. PubMed ID: 7371040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental study of chemotherapy of renal cell carcinoma. 2. Combination effect of interferon and antitumor agents based on cell kinetic analysis].
    Konami T
    Hinyokika Kiyo; 1987 Jan; 33(1):15-26. PubMed ID: 3577963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of the new mitotic inhibitor 5-chloropyrimidin-2-one and of vincristine on human cells in vitro.
    Wibe E; Oftebro R; Christensen T; Laland SG; Pettersen EO; Lindmo T
    Cancer Res; 1978 Mar; 38(3):560-5. PubMed ID: 626961
    [No Abstract]   [Full Text] [Related]  

  • 13. Suppression of vincristine-mediated cytotoxic activity by mitoxantrone in human cell lines.
    Ho CK; Au LC; Wang SY
    Anticancer Res; 1996; 16(5A):2645-51. PubMed ID: 8917364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic effects of sangivamycin in sarcoma 180 in vitro.
    Ritch PS; Glazer RI; Cunningham RE; Shackney SE
    Cancer Res; 1981 May; 41(5):1784-8. PubMed ID: 7214345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chartreusin on cell survival and cell cycle progression.
    Bhuyan BK; Robinson MI; Shugars KD; Bono VH; Dion RL
    Cancer Res; 1978 Sep; 38(9):2734-9. PubMed ID: 567096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of DNA topoisomerase IIalpha leads to prolonged cell cycle transit in G2 and early M phases and increased survival to microtubule-interacting agents.
    Skladanowski A; Côme MG; Sabisz M; Escargueil AE; Larsen AK
    Mol Pharmacol; 2005 Sep; 68(3):625-34. PubMed ID: 15942022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell cycle effects of CC-1065.
    Bhuyan BK; Crampton SL; Adams EG
    Cancer Res; 1983 Sep; 43(9):4227-32. PubMed ID: 6871861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can nocodazole, an inhibitor of microtubule formation, be used to synchronize mammalian cells? Accumulation of cells in mitosis studied by two parametric flow cytometry using acridine orange and by DNA distribution analysis.
    Nüsse M; Egner HJ
    Cell Tissue Kinet; 1984 Jan; 17(1):13-23. PubMed ID: 6692463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of action of E7010, an orally active sulfonamide antitumor agent: inhibition of mitosis by binding to the colchicine site of tubulin.
    Yoshimatsu K; Yamaguchi A; Yoshino H; Koyanagi N; Kitoh K
    Cancer Res; 1997 Aug; 57(15):3208-13. PubMed ID: 9242451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microfluorometric investigations on the cell cycle progression of experimental ascites tumors treated with alkaloidic drugs.
    Stöhr M; Fischinger W
    Arzneimittelforschung; 1978; 28(6):977-81. PubMed ID: 582007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.